TSHA-102

Drug identity has not yet been verified against registry records

A drug appearing in a clinical trial does not mean it is FDA-approved. Check the original regulatory source for any approval claim.

Included trials

TrialSponsorPhaseStatusPrimary completion
Safety and Preliminary Efficacy of TSHA-102 Gene Therapy in Pediatric Females Aged >2 to <4 Years With Rett SyndromeNCT07480564TSHAPhase 3Active not recruiting2031-06Estimated
A Phase 1/2/3 Study of TSHA-102 Gene Therapy in Females With Rett Syndrome (REVEAL Pivotal Study)NCT05606614TSHAPhase 3Active not recruiting2031-06Estimated

Regulatory dates and decisions

No regulatory events match this view.This does not mean no FDA events have occurred.